Dow Jones

40,326.46

0.10%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
UK
LSE
Celadon Pharmaceuticals Plc (CEL)
Celadon Pharmaceuticals Plc (CEL) News

CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

Last Updated: 14:00:11

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	11,271	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Annual Report Notification

03/07/2008 2:39pm

UK Regulatory

    RNS Number : 2749Y
  Celsis International PLC
  03 July 2008
   

    FOR release: Thursday 3 July 2008

    CELSIS INTERNATIONAL PLC
    ("Celsis", "the Company" or "the Group")

    Annual Report & Accounts

    3 July 2008: Celsis International plc, the international life sciences products and laboratory services company, today announces that
copies of the Company's Annual Report and Accounts 2008 have been submitted to the UK Listing Authority (UKLA) and will shortly be delivered
for inspection at the UKLA Document Viewing Facility, which is situated at:

    Financial Services Authority 
    25 The North Colonnade 
    London 
    E14 5HS 
    020 7066 1000

    For further information please contact:

    
 Celsis International plc                            Tel: +44 (0) 1223 598 428
 Christian Madrolle, Finance Director & Company                               
 Secretary
 Jenny Woolway, Corporate Communications                                      


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCBXGDRUXGGGIX